New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 28, 2014
15:32 EDTVASCVascular Solutions to pay $520K to resolve false claims charges
Vascular Solutions has agreed to pay $520,000 to resolve allegations that it caused false claims to be submitted to federal health programs by marketing a medical device for the ablation of perforator veins without FDA approval and despite the failure of its own clinical trial, the Justice Department announced. The allegations resolved by the settlement were raised in a lawsuit filed against VSI by DeSalle Bui, a former sales representative at VSI, under the qui tam, or whistleblower, provisions of the False Claims Act, which allow private citizens with knowledge of false claims to bring civil actions on behalf of the government and to share in any recovery.
News For VASC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2014
08:03 EDTVASCVascular Solutions receives FDA clearance for Gel-Block 10x embolization product
Subscribe for More Information
November 14, 2014
16:21 EDTVASCOn The Fly: Closing Wrap
Subscribe for More Information
12:58 EDTVASCOn The Fly: Midday Wrap
Subscribe for More Information
08:34 EDTVASCVascular Solutions weakness a buying opportunity, says Canaccord
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use